Insulin-Like Growth Factor 2 in Development and Disease: A Mini-Review
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Background: Insulin-like growth factor 2 (IGF2) is a protein hormone known to regulate cell proliferation, growth, migration, differentiation and survival. The gene is parentally imprinted in the sense that transcripts are almost exclusively derived from the paternal allele. Loss of imprinting of the IGF2 gene is a recurrent observation in growth disorders that combine overgrowth with a variety of malignant tumours. Moreover, IGF2 has been proposed to play a role in the development of a variety of seemingly unrelated cancers that play an important role in geriatric medicine, e.g. breast cancer, colon cancer and lung cancer. Finally, IGF2 has been implicated in cardiovascular disease, since, for example, IGF2 has been shown to influence the size of atherosclerotic lesions. Objective: To summarize current knowledge about IGF2, its interactions with binding proteins and receptors and connections with key diseases. Methods: The contents of this paper were based on reviews of existing literature within the field. Results: There is a substantial amount of research linking IGF2 to growth disorders, cancer and to a much lesser degree cardiovascular disease. Some of the studies on IGF2 and tumour growth have yielded conflicting results, for instance regarding its effect on apoptosis. Conclusion: Today, our knowledge on how IGF2 is composed and interacts with receptors has come a long way. However, there is comparatively little information on how IGF2 affects tumour growth and cardiovascular diseases such as atherosclerosis. Thus, further research will be needed to elucidate the impact of IGF2 on key diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Genes whose expression significantly decreased include Mki67 and Igf2, which have roles in promoting cellular proliferation40,41.”
From The single-cell transcriptional landscape of mammalian organogenesis (2019) · cites this paper as [41]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parental imprinting of the mouse insulin-like growth factor II gene
DeChiara, T. M., Robertson, E. J., & Efstratiadis, A. (1991) · Cell · doi:10.1016/0092-8674(91)90513-x · Cited by 1,783
Rinderknecht, E., & Humbel, R. E. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40889-1 · Cited by 1,545
Insulin-like growth factors and neoplasia
Pollak, M. N., Schernhammer, E. S., & Hankinson, S. E. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1387 · Cited by 1,463
A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro.
SALMON, W. D., & Daughaday, W. H. (1957) · PubMed · Cited by 1,084
Belfiore, A., Frasca, F., Pandini, G., Sciacca, L., & Vigneri, R. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0047 · Cited by 1,033
The Role of the IGF System in Cancer Growth and Metastasis: Overview and Recent Insights
Samani, A. A., Yakar, S., LeRoith, D., & Brodt, P. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0001 · Cited by 1,005
Primary structure of human insulin‐like growth factor II
Rinderknecht, E., & Humbel, R. E. (1978) · FEBS Letters · doi:10.1016/0014-5793(78)80237-3 · Cited by 780
Insulin-like growth factor binding proteins and their role in controlling IGF actions
Clemmons, D. R. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(96)00053-6 · Cited by 498
Structure and autoregulation of the insulin-like growth factor 1 receptor kinase.
Favelyukis, S., Till, J. H., Hubbard, S. R., & Miller, W. T. (2001) · Nature Structural Biology · doi:10.1038/nsb721 · Cited by 336
IGF2: Epigenetic regulation and role in development and disease
Chao, W., & D’Amore, P. A. (2008) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2008.01.005 · Cited by 336
Cited by
Items 201–260 of 260
Sun, H., Liu, Y., Zhang, Y., Wang, Y., Zhao, Y., & Liu, Y. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.971435 · Cited by 1
Sato, Y., Watanabe, Y., Morisaki, T., Hayashi, S., Otsubo, Y., Ochiai, Y., Mizoguchi, K., Takao, Y., Yamada, M., Mizuuchi, Y., et al. (2024) · Surgical Case Reports · doi:10.1186/s40792-024-01865-2 · Cited by 1
Lung proliferative lesion‐promoting effects of left pulmonary ligation in A/J female mice
Yokohira, M., Hashimoto, N., Yamakawa, K., Nakano‐Narusawa, Y., Matsuda, Y., & Imaida, K. (2020) · Pathology International · doi:10.1111/pin.12915 · Cited by 1
Maier, F., Frühwald, M. C., Heinrich, U., Schimmel, M., Wahl, D., & Eggermann, T. (2021) · Clinical Dysmorphology · doi:10.1097/mcd.0000000000000378 · Cited by 1
“3 (Tatton-Brown et al., 2009; Bergman et al., 2013).”
Molecular Analysis of the Involvements of lncRNA in Cancer Development
Bagchi, A. (2021) · Springer eBooks · doi:10.1007/978-981-15-4501-6_153-1 · Cited by 1
Wang, C., Yang, Y., Liu, Y., Zhang, Y., Song, J., Wang, H., Li, G., Wang, X., Gong, S., Chen, S.-F., et al. (2022) · Journal of Applied Animal Research · doi:10.1080/09712119.2022.2116441 · Cited by 1
(2023) · Journal of Population Therapeutics and Clinical Pharmacology · doi:10.47750/jptcp.2023.30.13.025 · Cited by 1
Shrilakshmi, S., Kundapura, S. V., Dey, D., Ananda, K., & Ramagopal, U. A. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/769497 · Cited by 1
Merten, C. C. (2020) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8145 · Cited by 1
Application of Multi-Omics Approaches to Maximize Beef Production
Naddafi, A. F. (2021) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3-dmka-4k42 · Cited by 1
Fowler, E. W., van Venrooy, E. J., Witt, R. L., & Jia, X. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.08.463706 · Cited by 1
Estudo das alterações na expressão gênica dos ependimomas
de Andrade, F. G. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2014.tde-01092014-154140
Kreidberg, J. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800102-8.00016-3
Ellberg, C. (2014) · Lund University Publications (Lund University)
Supplementary material to: IMPRINTING GENES ASSOCIATED WITH ENDOMETRIOSIS
Kobayashi, H. (2014)
Review article: IMPRINTING GENES ASSOCIATED WITH ENDOMETRIOSIS
Kobayashi, H. (2014)
Franks, S. E. (2015) · The Atrium (University of Guelph)
Developmental programming: the role of growth
Oberbauer, A. M. (2015)
Malignant Meme Tümörlü Köpeklerde Plazma IGF-2 Konsantrasyonu ve Tümör Dokusundaki Ekspresyonu
Anadol, E. (2016) · Atatürk Üniversitesi Veteriner Bilimleri Dergisi · doi:10.17094/ataunivbd.282987
“kanserlerinde, IGF-1 ve IGF-2 düzeyleri ile tümör gelişimi arasında korelasyon saptanırken, meme kanserinde herhangi bir korelasyon belirlenememiştir (10).”
BackgroundInfluentialVariantes genéticas de risco às fissuras orofaciais
Brito, L. A. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.41.2016.tde-01082016-100632
Genomic Imprinting: Matrilineal Regulatory Control Over Gene Expression
Keverne, E. B. (2017) · Cambridge University Press eBooks · doi:10.1017/9781108242080.004
Mechanisms of Igf2 inhibition in thymic epithelial cells infected by coxsackievirus CV-B4Preprint
Michaux, H., Halouani, A., Trussart, C., Renard, C., Jaïdane, H., Martens, H., Hober, D., & Geenen, V. G. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.10.902684
Growth hormone, somatomedins and cancer risk
Kozakowski, J., Dudek, P., & Zgliczyński, W. (2020) · Wiedza Medyczna · doi:10.36553/wm.57
da Silva, C. B. F. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.41.2020.tde-22062020-092347
Gültiken, N., Yarım, M., Yarım, G. F., Sözmen, M., Anadol, E., & Fındık, M. (2021) · Acta Veterinaria Hungarica · doi:10.1556/004.2021.00013
Kingshott, G., Biernacka, K. M., Sewell, A., Gwiti, P., Barker, R. M., Zielinska, H., Gilkes, A., McCarthy, K. L., Martin, R. M., Lane, J. A., et al. (2020) · doi:10.21203/rs.3.rs-135609/v1
“In vivo, a de ciency of RNA binding proteins may be also contributory, but an additional factor may be that circulating IGF-II peptide is unstable and may be susceptible to degradation [45].”
BackgroundTuo, H., Yao, B., He, B., Yu, S., Li, D., Li, W., & Jin, L. (2021) · Journal of Biomaterials and Tissue Engineering · doi:10.1166/jbt.2021.2747
Prospecção clínica e molecular de novos alvos terapêuticos em neoplasias mieloides
da Silva, J. L. C. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2021.tde-11062021-082258
Liu, R., Tearle, R. G., Low, W. Y., Chen, T., Thomsen, D. A., Smith, T. P. L., Hiendleder, S., & Williams, J. L. (2020) · Research Square · doi:10.21203/rs.3.rs-133550/v1
Caracterización de la vía de señalización intracelular mediada por IGF2R en trofoblasto humano
Badilla, C., & José, J. C. M. S. (2021)
Obesity epigenetics and exercise
Foster, S. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820682-9.00015-3
Grundskola eller särskola? : En undersökning om att välja skolform för barn med funktionsnedsättning
Arnberg, M., & Pierre, I. (2009) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Zhou, X., Yang, T., Li, X., Wei, T., Xu, Y., Mao, Y., & Chen, L. (2021) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2021.3189
Life course epidemiology and analysis
Mayeda, E. R., Binder, A. M., & Kobayashi, L. C. (2021) · doi:10.1093/med/9780198816805.003.0043
Mullen, E. A., Kreidberg, J. A., & Weldon, C. B. (2015) · Springer eBooks · doi:10.1007/978-3-662-43596-0_80
Sun, H., Liu, Y., Zhang, Y., Wang, Y., Cui, B., Zhao, Y., & Liu, Y. (2022) · medRxiv · doi:10.1101/2022.04.27.22274374
“The IGF2 protein has a 92 tumour-promoting effect on existing colorectal neoplasia([7-10]) and that LOI of IGF2 in either tissue or 93 peripheral blood leukocyte (PBL) samples is associated with an increased risk of CRC.”
BackgroundMolecular Analysis of the Involvements of lncRNA in Cancer Development
Bagchi, A. (2022) · Springer eBooks · doi:10.1007/978-981-15-9411-3_153
Faculty Opinions recommendation of Therapeutic targeting of the IGF axis.
Rosenzweig, S. A. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736449435.793572320
Furman, B. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.98025-5
Boldison, J., Hopkinson, J. R., Davies, J. E., Pearson, J. A., Leete, P., Richardson, S. J., Morgan, N. G., & Wong, F. S. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.19.492647
The imprinted Mir483 is a growth suppressor and metabolic regulator functioning through IGF1Preprint
Sandovici, I., Fernandez‐Twinn, D. S., Campbell, N., Cooper, W. N., Sekita, Y., Zvetkova, I., Ferland-McCollough, D., Prosser, H. M., Oyama, L. M., Cimadomo, D., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.09.507324
Costa, P. F. L., Lopes, J. V. N., Silva, C. T. N. E., Freitas, A. S., Cunha, S. D. M., Machado, F. S. M., Alves, M. R., Rodrigues, V. D., & de Barcellos, L. A. M. (2022) · RENEF · doi:10.46551/rn2022132000062
Collar-Fernández, C., Hoffmann, L. B., Fennell, K. A., Pang, T. Y., & Hannan, A. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-823937-7.00006-7
Expression of mechano-growth factor (MGF) in refractory overactive bladderPreprint
Spiritosanto, E., Lemmon, B., Mohamedi-Yousufi, F., Munasinghe, H., Mahmood, A., Bray, R., Mackenzie, F. E., Hill, N. J., & Cortes, E. (2023) · medRxiv · doi:10.1101/2023.12.08.23299594
“Insulin-like growth factor 1 (IGF-1) is a protein hormone involved in a broad range of processes including cell growth and survival, prolifera(cid:415)on, differen(cid:415)a(cid:415)on, and (cid:415)ssue metabolism [10, 11].”
BackgroundXie, Y., Xiao, J., Ying, Y., Liu, J., Zhang, L., & Zeng, X. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-02961-8
“Insulin-like growth factor 2 binding protein 2 (IGF2BP2) is a mRNA-binding protein that binds insulin-like growth factor 2, a regulator of development and growth (Woźniak et al. 2015; Bergman et al. 2013; Nielsen et al. 1999).”
Adverse outcome pathway: A paradigm shift in chemical toxicological analysis
Bhatele, S., Mhatre, M., Tekade, M., Vasdev, N., Pawar, B., & Tekade, R. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15842-1.00015-6
Premature cognitive decline in a mouse model of tuberous sclerosis
Krummeich, J., Nardi, L., Caliendo, C., Aschauer, D. F., Engelhardt, V., Arlt, A., Maier, J., Bicker, F., Kwiatkowski, M., Rolski, K., et al. (2024) · Aging Cell · doi:10.1111/acel.14318
IGF-II conjugated nanocarrier for brain targeting
Akotkar, L., Aswar, U. M., Shruti, S. D., Tushar, S., & Dhanshree, J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23841-3.00004-2
Barman, S., & Ganesan, S. K. (2025) · Human Gene · doi:10.1016/j.humgen.2025.201508
Zhou, X., Tan, B., Gui, W., Zhou, C., Zhao, H., Lin, X., & Li, H. (2023) · Figshare · doi:10.6084/m9.figshare.24655875
Liu, R., Tearle, R. G., Low, W. Y., Chen, T., Thomsen, D. A., Smith, T. P. L., Hiendleder, S., & Williams, J. L. (2021) · Figshare · doi:10.6084/m9.figshare.14728463
Zhou, X., Tan, B., Gui, W., Zhou, C., Zhao, H., Lin, X., & Li, H. (2024) · Figshare · doi:10.6084/m9.figshare.26646535
Liu, R., Tearle, R. G., Low, W. Y., Chen, T., Thomsen, D. A., Smith, T. P. L., Hiendleder, S., & Williams, J. L. (2021) · Figshare · doi:10.6084/m9.figshare.14728466
Zhou, X., Tan, B., Gui, W., Zhou, C., Zhao, H., Lin, X., & Li, H. (2024) · Figshare · doi:10.6084/m9.figshare.26646538
Zhou, X., Tan, B., Gui, W., Zhou, C., Zhao, H., Lin, X., & Li, H. (2024) · Figshare · doi:10.6084/m9.figshare.24656143
Function and regulatory mechanism of RNA-binding protein IGF2BP2 in obesity and cancers
Yi, R., Wu, R., & Jiang, Q. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11740-y
Development of a time-resolved fluoroimmunoassay for salmonid insulin-like growth factor-2
Izutsu, A., Suzuki, S., Kitade, H., & Shimizu, M. (2026) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2026.114976
Metadata
- Authors
- Bergman, D., Halje, M., Nordin, M., & Engström, W.
- Affiliations
- Swedish University of Agricultural Sciences (SE)
- ORCID
- Bergman, Daniel
- Venue
- Gerontology
- Publisher
- S. Karger AG
- Published
- 2012-12-20
- Volume
- 59
- Issue
- 3
- Pages
- 240-249
- ISSN
- 0304-324X (ISSN-L)
- 1423-0003
- OpenAlex
- W1976143235
- Cited by
- 260
- References
- 35
- Citations by year
- 2026: 4 · 2025: 13 · 2024: 27 · 2023: 21 · 2022: 27 · 2021: 35 · 2020: 37 · 2019: 13 · 2018: 15 · 2017: 15 · 2016: 17 · 2015: 17 · 2014: 15 · 2013: 3
- FWCI
- 1.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Gerontology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Keywords
- insulin-like growth factor II, genomic imprinting, loss of imprinting, overgrowth syndromes, cancer, breast cancer, colon cancer, lung cancer, cardiovascular disease, atherosclerosis, IGF-II receptor, apoptosis, tumor growth, geriatrics
- MeSH terms
- Animals, Cardiovascular Diseases, Disease, Female, Humans, Insulin-Like Growth Factor II, Male, Neoplasms, Protein Processing, Post-Translational, Receptor, Insulin, Signal Transduction, Receptor, IGF Type 1, Receptor, IGF Type 2, Genomic Imprinting, Insulin-Like Growth Factor Binding Proteins, Growth and Development, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.